On January 19, 2024, Chairman Peng Zhien and Director Li Jinliang of Aurisco Pharmaceutical Co., Ltd. were invited to participate in the "Future Pharmaceutical Industry-University-Research Development Forum under AI Empowerment and Pharmaceutical Discipline Development Conference of East China Normal University" held in neoBay Kechuang Building. During the meeting, the two sides signed a strategic framework agreement on school-enterprise cooperation to jointly promote the development and industrialization of AI-enabled small nucleic acid new drugs; And the company has become the "Biological and medical engineering master and Doctor internship practice base" of Easten China Normal University, and jointly cultivate high-level talents with innovative ability and suitable for the development of enterprises.